← All companies

EXOZ

eXoZymes, Inc.

EXOZ Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$4.62

+0.02 +0.43%

Key statistics

from XBRL data in SEC filings

Market cap

$39.2M

Revenue (TTM)

$70.1K

Net income (TTM)

-$9.67M

EPS (TTM)

$-1.15

P/E ratio

—

Dividend yield

—

Free cash flow

-$6.67M

Cash

$1.44M

Total assets

$4.02M

Gross margin

—

52-week range

$4.35 – $18.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement Jul 1, 2026 8-K Regulation FD disclosure Jun 26, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 17, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Other events May 7, 2026 8-K Other events Apr 10, 2026 8-K Other events Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Other events Feb 5, 2026 8-K Other events Dec 12, 2025 8-K Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Oct 3, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Shareholder vote results Jul 28, 2025 8-K Other events Jul 8, 2025 8-K Entered a material agreement Jun 26, 2025 8-K Director or officer change Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Other events Apr 2, 2025 8-K Other events Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change Feb 21, 2025 8-K Amended charter or bylaws Feb 11, 2025 8-K Entered a material agreement; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024

Other filings

424B5 Jun 30, 2026 424B5 Jun 8, 2026 424B5 Jun 4, 2026 424B5 May 29, 2026 4 Apr 10, 2026 424B5 Apr 9, 2026 4 Apr 8, 2026 3 Apr 8, 2026 4 Apr 8, 2026 4 Apr 8, 2026 4 Apr 8, 2026 4 Apr 8, 2026 424B2 Jan 26, 2026